Electroencephalographic changes in experimental autoimmune myasthenia gravis

Journal of the Neurological Sciences

Volumn 114, Issue 2, 1993, Pages 200-204

  Saphier, David ^a   Birmanns, Bettina ^b   Brenner, Talma ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acetylcholine receptor; Central nervous system; Cerebrospinal fluid; Electroencephalogram; Experimental autoimmune myasthenia gravis; Myasthenia gravis

Indexed keywords

ALPHA BUNGAROTOXIN; CHOLINERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMAL; ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FEMALE; MUSCLES; MYASTHENIA GRAVIS; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; REFERENCE VALUES; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027498892     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(93)90298-D     Document Type: Article

References (52)

1. Epileptic seizures in children with myasthenia gravis
2. α-Interferon modifies cortical EEG activity: dose-dependency and antagonism by naloxone
3. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit
4. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients
5. Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor
6. Evidence that central nicotinic-acetylcholine receptors are involved in the modulation of basal and stress-induced adrenocortical responses
7. Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats
8. In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients
9. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
10. Clinical and electroencephalographic changes induced by intracerebral infusion of serum from myasthenia gravis patients and α-bungarotoxin
11. Central nervous system involvement in myasthenia gravis
12. 3H]nicotine
13. Myasthenia gravis and epilepsy
14. Electroencephalographic findings in myasthenia gravis
15. Cognitive dysfunction in myasthenia gravis
16. EEG finding in myasthenia gravis
17. Acetylcholine receptor antibody in cerebrospinal fluid
18. Central administration of immunomodulatory factors alters neural activity and adrenocortical secretion
19. Interferon system and natural killer cell activity in myasthenia gravis
20. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions
21. Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis
22. Absence of central functional cholinergic deficits in myasthenia gravis
23. Molecular studies of the neuronal nicotinic acetylcholine receptor family
24. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls
25. Interactions of antinicotinic acetylcholine receptor antibodies with rat brain and muscle antigenic determinants
26. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671
27. Myasthenia gravis: psychiatric concomitants
28. Psychiatric disturbances associated with myasthenia gravis
29. Psychological disturbances in myasthenia gravis: a predictive study
30. Is interleukin-2 a neuromodula tor in the brain?
31. Current treatment of myasthenia gravis
32. Rapid eye movement sleep alterations in myasthenia gravis
33. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain
34. Neuroregulatory effects of nicotine
35. Relationship between the cortical choline acetyltransferase content and EEG delta-power
36. Behavior analysis in myasthenia gravis
37. Variations in slow wave activity during sleep in the rat
38. Neurophysiological and endocrine consequences of immune activity
39. Multiunit electrical activity in conscious rats during an immune response
40. Neurophysiological changes in the brain following central administration of immunomodulatory factors
41. REM sleep induction during sleep in normal volunteers
42. Adipsia and aphagia clicited by intracerebroventricular injections of antiacetylcholine receptor antibodies
43. EEG findings in 118 cases of myasthenia gravis
44. Phases and states of sleep in the rat
45. Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects
46. Cerebral activity and behavior: control by central cholinergic and serotonergic systems
47. Differential effects of cholinergic antagonists on REM sleep components
48. Anti-acetylcholine receptor antibodies
49. Central acetylcholine receptor function in patients with myasthenia gravis
50. Differential adrenocortical responses to neural stimuli following intracerebroventricular injection of nicotinic acetylcholine receptor antibodies in rats
51. Effect of intracerebroventricular injection of nicotinic acetylcholine receptor antibodies on ACTH, corticosterone and prolactin secretion in the male rat
52. Purification and characterization of a nicotinic acetylcholine receptor from rat brain